Referral of Patients With Biological Abnormalities to an Emergency Department

Biological testing is an essential part of general medical practice and plays a role in 60% to 70% of diagnoses. 68.5% of prescriptions are written by general practitioners, and one in seven general medical consultations ends with a prescription for biological testing. The study of patient trajectories is a recent emerging topic in the literature, encompassing general concepts. The angle most often taken is medico-economic and focused on specific chronic conditions such as diabetes, cancer, or cardiovascular disease. To our knowledge, there are a number of referrals to emergency departments by general practitioners for patients with biological abnormalities. However, to our knowledge, no study to date has attempted to quantify these specific referrals.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Biological Abnormality Emergency Department Visit General Practitioner

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHR Metz-Thionville

Metz, France, 57085

About this study

want to establish a register of biological anomaly referrals by general practitioners to emergency departments. This study will enable us to estimate the number of patients whose referral could have been handled differently, allowing us to develop dedicated care pathways, specialized training in outpatient settings, or targeted communications, ultimately leading to better patient referral and reducing inappropriate use of emergency services.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral "Abnormal laboratory results.

Exclusion criteria

minor patients (<18 years old)
expression of the patient's opposition to the collection of data relating to their hospital stay.

Treatment and study plan

Primary outcomes

Type of biological abnormality and severity level

Time frame: Immediately upon admission to the emergency room

The primary evaluation criterion is the type of biological abnormality sent to the emergency department and its severity (depth or elevation).

Study contacts

Contact information is provided by the study sponsor or research team.

Andreia CARVALHO DE FREITAS

CONTACT

[email protected]

0033387553323

Laure ABENSUR VUILLAUME

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Registry information

Official study title

Referral of Patients With Biological Abnormalities to an Emergency Department : ORA

Acronym: ORA

Important dates

Study start: 2026
Primary completion: 2027
Study completion: 2027
First posted: Feb 12, 2026
Registry last updated: Feb 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting